Technology Upgrade and Mass Production of Anti-tumor Pharmaceutical Intermediates
To meet market demand for highly effective, low-toxic anti-tumor drugs, the company invested in R&D to upgrade the technology of a specific anti-tumor pharmaceutical intermediate. By optimizing the reaction route and improving the production process, the company not only reduced production costs by 30% but also controlled the product impurity content to below 0.1%. The technological upgrade enabled large-scale mass production, supplying 20 tons of high-quality anti-tumor pharmaceutical intermediates to downstream pharmaceutical companies monthly, helping to increase the production capacity of multiple anti-tumor drugs.
Related Picks
The economic operation of the petrochemical industry in the first half of the year showed six major characteristicsOct 20 2025Recently, reporters learned at the 2025 National Petroleum and Chemical Industry Economic Situation Analysis Conference held in Nantong, Jiangsu that the economic operation of the petrochemical industry was basically stable in the first half of this year, showing six major characteristics.
In July, the added value of chemical raw materials and chemical products manufacturing increased by 7.2% year-on-yearOct 20 2025Recently, the National Bureau of Statistics released data showing that in July, the added value of industrial enterprises above designated size increased by 5.7% year-on-year in real terms. Among them, the oil and natural gas extraction industry increased by 4.1% year-on-year, and the chemical raw materials and chemical products manufacturing industry increased by 7.2% year-on-year.
Connecting with over 4,000 factories, a company launches a one-stop procurement service for chemical products.Sep 30 2025To address the pain points of high procurement costs and time-consuming procurement processes for customers, a company has integrated industry resources and established strategic partnerships with over 4,000 factories, providing one-stop procurement services for nearly 50,000 chemical products.
Covering Seven Therapeutic Areas! A Company's Pharmaceutical Intermediates Product Range Exceeds 330 CategoriesSep 30 2025A company deeply engaged in the pharmaceutical intermediates sector has achieved further success. Its pharmaceutical intermediates now cover seven therapeutic areas: anti-infectives, cardiovascular and cerebrovascular systems, digestive system, anti-tumor, neurological, geriatric, and gynecological medications, with a product range exceeding 330 categories.
Question Consultation
Send Us Your Inquiry Today
Whether you have inquiries about product specifications, pricing, delivery, or customized solutions, please leave us a detailed message. Our professional sales and technical team will respond to you promptly and provide one-stop support for your global procurement.